Deltex Medical Group plc
DEMG.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | £1,776 | £2,482 | £2,259 | £2,398 |
| % Growth | -28.4% | 9.9% | -5.8% | – |
| Cost of Goods Sold | £651 | £735 | £776 | £851 |
| Gross Profit | £1,125 | £1,747 | £1,483 | £1,547 |
| % Margin | 63.3% | 70.4% | 65.6% | 64.5% |
| R&D Expenses | £217 | £191 | £167 | £203 |
| G&A Expenses | £1,081 | £1,560 | £1,585 | £1,472 |
| SG&A Expenses | £1,766 | £2,604 | £2,542 | £2,436 |
| Sales & Mktg Exp. | £685 | £1,027 | £957 | £964 |
| Other Operating Expenses | £194 | £0 | £57 | £171 |
| Operating Expenses | £2,177 | £2,795 | £2,643 | £2,587 |
| Operating Income | -£1,052 | -£1,048 | -£1,160 | -£1,040 |
| % Margin | -59.2% | -42.2% | -51.4% | -43.4% |
| Other Income/Exp. Net | -£313 | -£169 | -£230 | -£172 |
| Pre-Tax Income | -£1,365 | -£1,217 | -£1,035 | -£846 |
| Tax Expense | -£83 | -£72 | -£69 | -£61 |
| Net Income | -£1,282 | -£1,149 | -£967 | -£798 |
| % Margin | -72.2% | -46.3% | -42.8% | -33.3% |
| EPS | -0.001 | -0.002 | -0.002 | -0.002 |
| % Growth | 35.3% | 0% | -13.3% | – |
| EPS Diluted | -0.001 | -0.002 | -0.002 | -0.002 |
| Weighted Avg Shares Out | 1,181,215 | 685,491 | 580,712 | 526,449 |
| Weighted Avg Shares Out Dil | 1,181,215 | 685,491 | 580,712 | 526,449 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £230 | £199 | £173 | £172 |
| Depreciation & Amortization | £133 | £128 | £114 | £143 |
| EBITDA | -£1,002 | -£819 | -£748 | -£531 |
| % Margin | -56.4% | -33% | -33.1% | -22.1% |